Abstract
α1,3/4-Fucosyltransferase was cloned firstly among the members of the α1,3-fucosyltransferase (α1,3FUT) family (Kukowska-Latallo et al. 1990) and named Fuc-TIII by J. Lowe et al. or FUT3 by Oriol et al. Later FUT3 (Fuc-TIII) was demonstrated to be the Lewis enzyme that determines the expression of Lewis histo-blood group antigens, i.e., Lewis a (Lea) and b (Leb) (Mollicone et al. 1994; Nishihara et al. 1994). FUT3 catalyzes transfer of fucose from GDP-fucose to the GlcNAc residue of type-2 chain, Galb1-4GlcNAc, with an α1,3-linkage, or to the GlcNAc residue of type-1 chain, Galb1-3GlcNAc, with an α1,4-linkage. The biosynthetic pathways of Lewis antigen epitopes in relation to ABH antigens are summarized in Fig. 48.1.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cakir B, Heiss G, Pankow JS, Salomaa V, Sharrett AR, Couper D, Weston BW (2004) Association of the Lewis genotype with cardiovascular risk factors and subclinical carotid atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) study. J Intern Med 255:40–51
Cameron HS, Szczepaniak D, Weston BW (1995) Expression of human chromosome 19p α(1,3)-fucosyltransferase genes in normal tissues. Alternative splicing, polyadenylation, and isoforms. J Biol Chem 270:20112–20122
Costache M, Apoil PA, Cailleau A, Elmgren A, Larson G, Henry S, Blancher A, Iordachescu D, Oriol R, Mollicone R (1997) Evolution of fucosyltransferase genes in vertebrates. J Biol Chem 272:29721–29728
de Vries T, Norberg T, Lonn H, Van den Eijnden DH (1993) The use of human milk fucosyltransferase in the synthesis of tumor-associated trimeric X determinants. Eur J Biochem 216:769–777
De Vries T, Srnka CA, Palcic MM, Swiedler SJ, van den Eijnden DH, Macher BA (1995) Acceptor specificity of different length constructs of human recombinant α1,3/4-fucosyltransferases. Replacement of the stem region and the transmembrane domain of fucosyltransferase V by protein A results in an enzyme with GDP-fucose hydrolyzing activity. J Biol Chem 270:8712–8722
De Vries T, Palcic MP, Schoenmakers PS, Van Den Eijnden DH, Joziasse DH (1997) Acceptor specificity of GDP-Fuc:Gal β1->4GlcNAc-R α3-fucosyltransferase VI (FucT VI) expressed in insect cells as soluble, secreted enzyme. Glycobiology 7:921–927
Djousse L, Karamohamed S, Herbert AG, D’Agostino RB, Cupples LA, Ellison RC (2007) Fucosyltransferase 3 polymorphism and atherothrombotic disease in the Framingham offspring study. Am Heart J 153:636–639
Dupuy F, Germot A, Julien R, Maftah A (2004) Structure/function study of Lewis α3- and α3/4-fucosyltransferases: the α1,4 fucosylation requires an aromatic residue in the acceptor-binding domain. Glycobiology 14:347–356
Elmgren A, Mollicone R, Costache M, Borjeson C, Oriol R, Harrington J, Larson G (1997) Significance of individual point mutations, T202C and C314T, in the human Lewis (FUT3) gene for expression of Lewis antigens by the human α(1,3/1,4)-fucosyltransferase, Fuc-TIII. J Biol Chem 272:21994–21998
Falk PG, Bry L, Holgersson J, Gordon JI (1995) Expression of a human α-1,3/4-fucosyltransferase in the pit cell lineage of FVB/N mouse stomach results in production of Leb-containing glycoconjugates: a potential transgenic mouse model for studying Helicobacter pylori infection. Proc Natl Acad Sci USA 92:1515–1519
Gersten KM, Natsuka S, Trinchera M, Petryniak B, Kelly RJ, Hiraiwa N, Jenkins NA, Gilbert DJ, Copeland NG, Lowe JB (1995) Molecular cloning, expression, chromosomal assignment, and tissue-specific expression of a murine α-(1,3)-fucosyltransferase locus corresponding to the human ELAM-1 ligand fucosyl transferase. J Biol Chem 270:25047–25056
Grabenhorst E, Nimtz M, Costa J, Conradt HS (1998) In vivo specificity of human α1,3/4-fucosyltransferases III-VII in the biosynthesis of LewisX and Sialyl LewisX motifs on complex-type N-glycans. Coexpression studies from bhk-21 cells together with human beta-trace protein. J Biol Chem 273:30985–30994
Henry S, Mollicone R, Fernandez P, Samuelsson B, Oriol R, Larson G (1996) Molecular basis for erythrocyte Le(a+b+) and salivary ABH partial-secretor phenotypes fucosyltransferase activity. Glycoconj J 13:985–993
Ikehara Y, Nishihara S, Kudo T, Hiraga T, Morozumi K, Hattori T, Narimatsu H (1998) The aberrant expression of Lewis a antigen in intestinal metaplastic cells of gastric mucosa is caused by augmentation of Lewis enzyme expression. Glycoconj J 15:799–807
Johnson PH, Donald AS, Watkins WM (1993) Purification and properties of the alpha-3/4-L-fucosyltransferase released into the culture medium during the growth of the human A431 epidermoid carcinoma cell line. Glycoconj J 10:152–164
Johnson PH, Watkins WM (1992) Purification of the Lewis blood-group gene associated alpha-3/4-fucosyltransferase from human milk: an enzyme transferring fucose primarily to type 1 and lactose-based oligosaccharide chains. Glycoconj J 241–249
Kaneko M, Kudo T, Iwasaki H, Ikehara Y, Nishihara S, Nakagawa S, Sasaki K, Shiina T, Inoko H, Saitou N, Narimatsu H (1999) α1,3-fucosyltransferase IX (Fuc-TIX) is very highly conserved between human and mouse; molecular cloning, characterization and tissue distribution of human Fuc-TIX. FEBS Lett 452:237–242
Kauffmann F, Frette C, Pham QT, Nafissi S, Bertrand JP, Oriol R (1996) Associations of blood group-related antigens to FEV1, wheezing, and asthma. Am J Respir Crit Care Med 153:76–82
Kudo T, Iwasaki H, Nishihara S, Shinya N, Ando T, Narimatsu I, Narimatsu H (1996) Molecular genetic analysis of the human Lewis histo-blood group system. II. Secretor gene inactivation by a novel single missense mutation A385T in Japanese nonsecretor individuals. J Biol Chem 271:9830–9837
Kukowska-Latallo JF, Larsen RD, Nair RP, Lowe JB (1990) A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group α(1,3/1,4)fucosyltransferase. Genes Dev 4:1288–1303
Mollicone R, Reguigne I, Kelly RJ, Fletcher A, Watt J, Chatfield S, Aziz A, Cameron HS, Weston BW, Lowe JB (1994) Molecular basis for Lewis α(1,3/1,4)-fucosyltransferase gene deficiency (FUT3) found in Lewis-negative Indonesian pedigrees. J Biol Chem 269:20987–20994
Nakayama T, Watanabe M, Katsumata T, Teramoto T, Kitajima M (1995) Expression of sialyl Lewis(a) as a new prognostic factor for patients with advanced colorectal carcinoma. Cancer 75:2051–2056
Narimatsu H, Iwasaki H, Nakayama F, Ikehara Y, Kudo T, Nishihara S, Sugano K, Okura H, Fujita S, Hirohashi S (1998) Lewis and secretor gene dosages affect CA19-9 and DU-PAN-2 serum levels in normal individuals and colorectal cancer patients. Cancer Res 58:512–518
Nishihara S, Nakazato M, Kudo T, Kimura H, Ando T, Narimatsu H (1993a) Human α-1,3 fucosyltransferase (FucT-VI) gene is located at only 13 kb 3′ to the Lewis type fucosyltransferase (FucT-III) gene on chromosome 19. Biochem Biophys Res Commun 190:42–46
Nishihara S, Yazawa S, Iwasaki H, Nakazato M, Kudo T, Ando T, Narimatsu H (1993b) α(1,3/1,4)fucosyltransferase (FucT-III) gene is inactivated by a single amino acid substitution in Lewis histo-blood type negative individuals. Biochem Biophys Res Commun 196:624–631
Nishihara S, Narimatsu H, Iwasaki H, Yazawa S, Akamatsu S, Ando T, Seno T, Narimatsu I (1994) Molecular genetic analysis of the human Lewis histo-blood group system. J Biol Chem 269:29271–29278
Nishihara S, Iwasaki H, Kaneko M, Tawada A, Ito M, Narimatsu H (1999) α1,3-fucosyltransferase 9 (FUT9; Fuc-TIX) preferentially fucosylates the distal GlcNAc residue of polylactosamine chain while the other four a1,3FUT members preferentially fucosylate the inner GlcNAc residue. FEBS Lett 462:289–294
Oulmouden A, Wierinckx A, Petit JM, Costache M, Palcic MM, Mollicone R, Oriol R, Julien R (1997) Molecular cloning and expression of a bovine α(1,3)-fucosyltransferase gene homologous to a putative ancestor gene of the human FUT3-FUT5-FUT6 cluster. J Biol Chem 272:8764–8773
Shirato H, Ogawa S, Ito H, Sato T, Kameyama A, Narimatsu H, Xiaofan Z, Miyamura T, Wakita T, Ishii K, Takeda N (2008) Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding. J Virol 82:10756–10767
Soejima M, Munkhtulga L, Iwamoto S, Koda Y (2009) Genetic variation of FUT3 in Ghanaians, Caucasians, and Mongolians. Transfusion 49:959–966
Solter D, Knowles BB (1978) Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci USA 75:5565–5569
Takada A, Ohmori K, Yoneda T, Tsuyuoka K, Hasegawa A, Kiso M, Kannagi R (1993) Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res 53:354–361
Togayachi A, Kudo T, Ikehara Y, Iwasaki H, Nishihara S, Andoh T, Higashiyama M, Kodama K, Nakamori S, Narimatsu H (1999) Up-regulation of Lewis enzyme (Fuc-TIII) and plasma-type α1,3fucosyltransferase (Fuc-TVI) expression determines the augmented expression of sialyl Lewis x antigen in non-small cell lung cancer. Int J Cancer 83:70–79
Yazawa S, Nishihara S, Iwasaki H, Asao T, Nagamachi Y, Matta KL, Narimatsu H (1995) Genetic and enzymatic evidence for Lewis enzyme expression in Lewis-negative cancer patients. Cancer Res 55:1473–1478
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Japan
About this entry
Cite this entry
Kudo, T., Narimatsu, H. (2014). Fucosyltransferase 3. GDP-Fucose Lactosamine α1,3/4-Fucosyltransferase. Lea and Leb Histo-Blood Groups (FUT3, Lewis Enzyme). In: Taniguchi, N., Honke, K., Fukuda, M., Narimatsu, H., Yamaguchi, Y., Angata, T. (eds) Handbook of Glycosyltransferases and Related Genes. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54240-7_94
Download citation
DOI: https://doi.org/10.1007/978-4-431-54240-7_94
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54239-1
Online ISBN: 978-4-431-54240-7
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences